The Controversial Role of Irisin in Clinical Management of Coronary Heart Disease

MLA

Wen-Lu Ou-Yang, et al. “The Controversial Role of Irisin in Clinical Management of Coronary Heart Disease.” Frontiers in Endocrinology, vol. 12, July 2021. EBSCOhost, https://doi.org/10.3389/fendo.2021.678309.

APA

Wen-Lu Ou-Yang, Bei Guo, Feng Xu, Xiao Lin, Fu-Xing-Zi Li, Su-Kang Shan, Feng Wu, Yi Wang, Ming-Hui Zheng, Qiu-Shuang Xu, & Ling-Qing Yuan. (2021). The Controversial Role of Irisin in Clinical Management of Coronary Heart Disease. Frontiers in Endocrinology, 12. https://doi.org/10.3389/fendo.2021.678309

Chicago

Wen-Lu Ou-Yang, Bei Guo, Feng Xu, Xiao Lin, Fu-Xing-Zi Li, Su-Kang Shan, Feng Wu, et al. 2021. “The Controversial Role of Irisin in Clinical Management of Coronary Heart Disease.” Frontiers in Endocrinology 12 (July). doi:10.3389/fendo.2021.678309.